Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
3,198
Views
3
CrossRef citations to date
0
Altmetric
Musculoskeletal
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia
Natalya Danchenkoa Ipsen, Boulogne-Billancourt, FranceCorrespondence[email protected]
, Karissa M. Johnstonb Broadstreet Health Economics and Outcomes Research, Vancouver, Canada
& John Whalenc Ipsen Slough, London, UK
Pages 919-929
|
Received 11 Mar 2022, Accepted 17 Jun 2022, Published online: 15 Jul 2022
Related Research Data
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.